Global Transient Ischemic Attack Market Research and Forecast, 2018-2023
Transient ischemic attacks or mini-strokes are often caused by the loss of blood flow in the retina, spinal cord or brain. The effect of the stroke doesn’t last for long and even doesn’t cause any permanent damage to the person; however, the chances of occurrence of major stroke becomes very likely for the person once contracted with a mini-stroke. The excessive consumption of alcohol and an increased number of smokers is one of the major factors driving the market growth across the globe. Moreover, the rapid increase in cardiac and neurological disorders are owing to the high cholesterol level and high blood pressure are some other factors fueling the market growth. The high treatment cost and lack of awareness about diagnosis and treatment of the diseases, majorly in emerging and underdeveloped economies significantly restrain the growth of the market. The increased government spending on healthcare facilities and technological advancement in diagnostic tools and treatment technologies is anticipated to mark growth opportunities for the market in the near future.
Geographically, the market is divided into North America, Europe, Asia-Pacific, and Rest of the World. North America holds a dominant position in the global transient ischemic attack market due to the presence of a large number of patients with neurological disorders and cardiac diseases. Moreover, the availability of advanced healthcare facilities further augments the market growth in the region. Asia-Pacific is projected to exhibit the fastest growth rate in the global transient ischemic attack market during the forecast period. This is mainly owing to the adoption of a sedentary lifestyle and increasing consumption of tobacco and alcohol in the region. Europe holds a second dominant position in the global transient ischemic attack market, owing to the high focus of government organizations in the development of healthcare infrastructure and increasing awareness about treatment and diagnosis of minor stroke.
The company engaged in transient ischemic attack market are continuously developing various types of medications and diagnostic devices for the treatment of the disease. Some of the key players operating in the transient ischemic attack market are Abbott Laboratories, Bayer AG, Boston Scientific Corp., Cardinal Health, Inc., electroCore, Inc., GE Healthcare, LivaNova PLC, Medtronic, PLC, Merck KGaA, Novartis AG, Novo Nordisk A/S, and Sanofi SA, among others. The companies are working on developing innovative valvular heart diseases treatment system through research and innovation, expansion, M&A, product launch of the innovative product in their core competency in order to expand individual market share.
RESEARCH METHODOLOGY
The market study of global transient ischemic attack market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
SECONDARY SOURCES INCLUDE
MARKET SEGMENTATION
Global transient ischemic attack market is segmented on the basis of various regions and below mentioned segments:
1. Global Transient Ischemic Attack Market Research and Analysis by Diagnosis
2. Global Transient Ischemic Attack Market Research and Analysis by Treatment
3. Global Transient Ischemic Attack Market Research and Analysis by End-Users
4. Global Transient Ischemic Attack Market Research and Analysis by Region
The report covers
Geographically, the market is divided into North America, Europe, Asia-Pacific, and Rest of the World. North America holds a dominant position in the global transient ischemic attack market due to the presence of a large number of patients with neurological disorders and cardiac diseases. Moreover, the availability of advanced healthcare facilities further augments the market growth in the region. Asia-Pacific is projected to exhibit the fastest growth rate in the global transient ischemic attack market during the forecast period. This is mainly owing to the adoption of a sedentary lifestyle and increasing consumption of tobacco and alcohol in the region. Europe holds a second dominant position in the global transient ischemic attack market, owing to the high focus of government organizations in the development of healthcare infrastructure and increasing awareness about treatment and diagnosis of minor stroke.
The company engaged in transient ischemic attack market are continuously developing various types of medications and diagnostic devices for the treatment of the disease. Some of the key players operating in the transient ischemic attack market are Abbott Laboratories, Bayer AG, Boston Scientific Corp., Cardinal Health, Inc., electroCore, Inc., GE Healthcare, LivaNova PLC, Medtronic, PLC, Merck KGaA, Novartis AG, Novo Nordisk A/S, and Sanofi SA, among others. The companies are working on developing innovative valvular heart diseases treatment system through research and innovation, expansion, M&A, product launch of the innovative product in their core competency in order to expand individual market share.
RESEARCH METHODOLOGY
The market study of global transient ischemic attack market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
SECONDARY SOURCES INCLUDE
- Financial reports of companies involved in the market
- Authentic Public Databases
- Whitepapers such as research papers and news blogs
- Company websites and their product catalog.
MARKET SEGMENTATION
Global transient ischemic attack market is segmented on the basis of various regions and below mentioned segments:
1. Global Transient Ischemic Attack Market Research and Analysis by Diagnosis
2. Global Transient Ischemic Attack Market Research and Analysis by Treatment
3. Global Transient Ischemic Attack Market Research and Analysis by End-Users
4. Global Transient Ischemic Attack Market Research and Analysis by Region
The report covers
- Comprehensive research methodology of global transient ischemic attack market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global transient ischemic attack market.
- Insights about market determinants which are stimulating the global transient ischemic attack market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
1. REPORT SUMMARY
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. MARKET OVERVIEW AND INSIGHTS
2.1. Definition
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Rules & Regulation
3. MARKET DETERMINANT
3.1. Motivators
3.1.1. Rising Prevalence of Cardiovascular Diseases
3.1.2. Sedentary Lifestyle and Faulty Dietary Habits
3.1.3. Rising Prevalence of Neurological Disorder
3.1.4. Favorable Reimbursement Policies
3.2. Restraint
3.2.1. High Cost of Treatment
3.2.2. Lack of Awareness Regarding Diagnosis and Treatment of TIA
3.3. OPPORTUNITY
3.3.1. Increased Investment by Government organizations in R&D
3.3.2. Technological Advancement in Diagnostic Tools for the treatment of Epilepsy
4. MARKET SEGMENTATION
4.1. Global Transient Ischemic Attack Market by Diagnosis
4.1.1. Carotid Ultrasonography
4.1.2. CT Scan and CT Angiography Scan
4.1.3. MRI Scan and MR Angiography
4.1.4. Echocardiography
4.1.5. Electrocardiogram
4.1.6. Others (Arteriography)
4.2. Global Transient Ischemic Attack Market by Treatment
4.2.1. Medication
4.2.1.1. Anti-Platelet Drugs
4.2.1.2. Anticoagulants
4.2.1.3. Thrombolytic Agents
4.2.2. Surgery
4.2.3. Angioplasty
4.3. Global Transient Ischemic Attack Market by End-Users
4.3.1. Hospital & Clinics
4.3.2. Research Institutes
4.3.3. Diagnostic Centers
5. COMPETITIVE LANDSCAPE
5.1. Key Strategy Analysis
5.2. Key Company Analysis
6. REGIONAL ANALYSIS
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Spain
6.2.4. France
6.2.5. Italy
6.2.6. RoE
6.3. Asia-Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World (RoW)
7. COMPANY PROFILES
7.1. Abbott Laboratories
7.2. Bayer AG
7.3. Boston Scientific Corp.
7.4. Cardinal Health, Inc.
7.5. Cigna Corp.
7.6. DAIICHI SANKYO CO., LTD.
7.7. electroCore, Inc.
7.8. Eli Lilly and CO.
7.9. General Electric Co.
7.10. LivaNova PLC
7.11. Medtronic, PLC
7.12. Merck KGaA
7.13. Novartis AG
7.14. Novo Nordisk A/S
7.15. Pfizer Inc.
7.16. Sanofi SA
7.17. Siemens Healthcare Pvt. Ltd.
7.18. Stryker Corp.
7.19. TERUMO CORP.
7.20. Zocere, Inc.
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. MARKET OVERVIEW AND INSIGHTS
2.1. Definition
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Rules & Regulation
3. MARKET DETERMINANT
3.1. Motivators
3.1.1. Rising Prevalence of Cardiovascular Diseases
3.1.2. Sedentary Lifestyle and Faulty Dietary Habits
3.1.3. Rising Prevalence of Neurological Disorder
3.1.4. Favorable Reimbursement Policies
3.2. Restraint
3.2.1. High Cost of Treatment
3.2.2. Lack of Awareness Regarding Diagnosis and Treatment of TIA
3.3. OPPORTUNITY
3.3.1. Increased Investment by Government organizations in R&D
3.3.2. Technological Advancement in Diagnostic Tools for the treatment of Epilepsy
4. MARKET SEGMENTATION
4.1. Global Transient Ischemic Attack Market by Diagnosis
4.1.1. Carotid Ultrasonography
4.1.2. CT Scan and CT Angiography Scan
4.1.3. MRI Scan and MR Angiography
4.1.4. Echocardiography
4.1.5. Electrocardiogram
4.1.6. Others (Arteriography)
4.2. Global Transient Ischemic Attack Market by Treatment
4.2.1. Medication
4.2.1.1. Anti-Platelet Drugs
4.2.1.2. Anticoagulants
4.2.1.3. Thrombolytic Agents
4.2.2. Surgery
4.2.3. Angioplasty
4.3. Global Transient Ischemic Attack Market by End-Users
4.3.1. Hospital & Clinics
4.3.2. Research Institutes
4.3.3. Diagnostic Centers
5. COMPETITIVE LANDSCAPE
5.1. Key Strategy Analysis
5.2. Key Company Analysis
6. REGIONAL ANALYSIS
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Spain
6.2.4. France
6.2.5. Italy
6.2.6. RoE
6.3. Asia-Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World (RoW)
7. COMPANY PROFILES
7.1. Abbott Laboratories
7.2. Bayer AG
7.3. Boston Scientific Corp.
7.4. Cardinal Health, Inc.
7.5. Cigna Corp.
7.6. DAIICHI SANKYO CO., LTD.
7.7. electroCore, Inc.
7.8. Eli Lilly and CO.
7.9. General Electric Co.
7.10. LivaNova PLC
7.11. Medtronic, PLC
7.12. Merck KGaA
7.13. Novartis AG
7.14. Novo Nordisk A/S
7.15. Pfizer Inc.
7.16. Sanofi SA
7.17. Siemens Healthcare Pvt. Ltd.
7.18. Stryker Corp.
7.19. TERUMO CORP.
7.20. Zocere, Inc.
LIST OF TABLES
TABLE # 1 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023($ MILLION)
TABLE # 2 GLOBAL CAROTID ULTRASONOGRAPHY MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
TABLE # 3 GLOBAL CT SCAN AND CT ANGIOGRAPHY SCAN MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
TABLE # 4 GLOBAL MRI SCAN AND MR ANGIOGRAPHY MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
TABLE # 5 GLOBAL ECHOCARDIOGRAPHY MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
TABLE # 6 GLOBAL ELECTROCARDIOGRAM MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
TABLE # 7 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
TABLE # 8 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023($ MILLION)
TABLE # 9 GLOBAL MEDICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
TABLE # 10 GLOBAL SURGERY RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
TABLE # 11 GLOBAL ANGIOPLASTY RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
TABLE # 12 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY END-USERS, 2017-2023($ MILLION)
TABLE # 13 GLOBAL HOSPITAL & CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
TABLE # 14 GLOBAL RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
TABLE # 15 GLOBAL DIAGNOSTIC CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
TABLE # 16 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023($ MILLION)
TABLE # 17 NORTH AMERICA TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023($ MILLION)
TABLE # 18 NORTH AMERICA TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023($ MILLION)
TABLE # 19 NORTH AMERICA TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY END-USERS, 2017-2023($ MILLION)
TABLE # 20 NORTH AMERICA TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023($ MILLION)
TABLE # 21 EUROPE TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023($ MILLION)
TABLE # 22 EUROPE TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023($ MILLION)
TABLE # 23 EUROPE TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY END-USERS, 2017-2023($ MILLION)
TABLE # 24 EUROPE TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023($ MILLION)
TABLE # 25 ASIA-PACIFIC TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023($ MILLION)
TABLE # 26 ASIA-PACIFIC TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023($ MILLION)
TABLE # 27 ASIA-PACIFIC TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY END-USERS, 2017-2023($ MILLION)
TABLE # 28 ASIA-PACIFIC TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023($ MILLION)
TABLE # 29 ROW TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023($ MILLION)
TABLE # 30 ROW TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023($ MILLION)
TABLE # 31 ROW TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY END-USERS, 2017-2023($ MILLION)
TABLE # 1 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023($ MILLION)
TABLE # 2 GLOBAL CAROTID ULTRASONOGRAPHY MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
TABLE # 3 GLOBAL CT SCAN AND CT ANGIOGRAPHY SCAN MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
TABLE # 4 GLOBAL MRI SCAN AND MR ANGIOGRAPHY MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
TABLE # 5 GLOBAL ECHOCARDIOGRAPHY MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
TABLE # 6 GLOBAL ELECTROCARDIOGRAM MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
TABLE # 7 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
TABLE # 8 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023($ MILLION)
TABLE # 9 GLOBAL MEDICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
TABLE # 10 GLOBAL SURGERY RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
TABLE # 11 GLOBAL ANGIOPLASTY RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
TABLE # 12 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY END-USERS, 2017-2023($ MILLION)
TABLE # 13 GLOBAL HOSPITAL & CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
TABLE # 14 GLOBAL RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
TABLE # 15 GLOBAL DIAGNOSTIC CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
TABLE # 16 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023($ MILLION)
TABLE # 17 NORTH AMERICA TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023($ MILLION)
TABLE # 18 NORTH AMERICA TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023($ MILLION)
TABLE # 19 NORTH AMERICA TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY END-USERS, 2017-2023($ MILLION)
TABLE # 20 NORTH AMERICA TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023($ MILLION)
TABLE # 21 EUROPE TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023($ MILLION)
TABLE # 22 EUROPE TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023($ MILLION)
TABLE # 23 EUROPE TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY END-USERS, 2017-2023($ MILLION)
TABLE # 24 EUROPE TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023($ MILLION)
TABLE # 25 ASIA-PACIFIC TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023($ MILLION)
TABLE # 26 ASIA-PACIFIC TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023($ MILLION)
TABLE # 27 ASIA-PACIFIC TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY END-USERS, 2017-2023($ MILLION)
TABLE # 28 ASIA-PACIFIC TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023($ MILLION)
TABLE # 29 ROW TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023($ MILLION)
TABLE # 30 ROW TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023($ MILLION)
TABLE # 31 ROW TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY END-USERS, 2017-2023($ MILLION)
LIST OF FIGURES
FIGURE # 1 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET SHARE BY DIAGNOSIS, 2017 VS 2023($ MILLION)
FIGURE # 2 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET SHARE BY TREATMENT, 2017 VS 2023($ MILLION)
FIGURE # 3 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET SHARE BY END-USERS, 2017 VS 2023($ MILLION)
FIGURE # 4 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET SHARE BY GEOGRAPHY, 2017 VS 2023($ MILLION)
FIGURE # 5 US TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 6 CANADA TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 7 UK TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 8 GERMANY TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 9 SPAIN TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 10 FRANCE TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 11 ITALY TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 12 ROE TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 13 INDIA TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 14 CHINA TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 15 JAPAN TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 16 REST OF ASIA-PACIFIC TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 17 ROW TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 1 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET SHARE BY DIAGNOSIS, 2017 VS 2023($ MILLION)
FIGURE # 2 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET SHARE BY TREATMENT, 2017 VS 2023($ MILLION)
FIGURE # 3 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET SHARE BY END-USERS, 2017 VS 2023($ MILLION)
FIGURE # 4 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET SHARE BY GEOGRAPHY, 2017 VS 2023($ MILLION)
FIGURE # 5 US TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 6 CANADA TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 7 UK TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 8 GERMANY TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 9 SPAIN TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 10 FRANCE TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 11 ITALY TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 12 ROE TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 13 INDIA TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 14 CHINA TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 15 JAPAN TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 16 REST OF ASIA-PACIFIC TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 17 ROW TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
